腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版)

2023-02-01 中国抗癌协会胰腺癌专业委员会微创诊治学组 中国实用外科杂志 发表于四川省

虽然胰腺外科手术历史已逾百年,但由于有较高的并发症发生率与死亡率,仍被认为是腹部外科最具挑战的手术之一。自1994年Gagner等报道了世界首例腹腔镜胰十二指肠切除术(laparoscopic pan

中文标题:

腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版)

发布日期:

2023-02-01

简要介绍:

虽然胰腺外科手术历史已逾百年,但由于有较高的并发症发生率与死亡率,仍被认为是腹部外科最具挑战的手术之一。自1994年Gagner等报道了世界首例腹腔镜胰十二指肠切除术(laparoscopic pancreatoduodenectomy,LPD)以来,有关学者一直在开展腹腔镜或机器人辅助技术应用于胰腺外科的探索工作[1]。近十年来,临床上陆续开展以腹腔镜或机器人辅助为主的各类胰腺微创手术,技术趋于成熟,手术安全性明显提高。理论上,腹腔镜或机器人辅助手术能开展的胰腺手术类型与开放手术已几乎无差异,

相关资料下载:
[AttachmentFileName(sort=1, fileName=腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=b6eae1c003015ee4, title=腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版), enTitle=, guiderFrom=中国实用外科杂志, authorId=0, author=, summary=虽然胰腺外科手术历史已逾百年,但由于有较高的并发症发生率与死亡率,仍被认为是腹部外科最具挑战的手术之一。自1994年Gagner等报道了世界首例腹腔镜胰十二指肠切除术(laparoscopic pan, cover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, journalId=0, articlesId=null, associationId=4292, associationName=中国抗癌协会胰腺癌专业委员会微创诊治学组, associationIntro=中国抗癌协会胰腺癌专业委员会微创诊治学组, copyright=0, guiderPublishedTime=Wed Feb 01 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">虽然胰腺外科手术历史已逾百年,但由于有较高的并发症发生率与死亡率,仍被认为是腹部外科最具挑战的手术之一。自1994年Gagner等报道了世界首例腹腔镜胰十二指肠切除术(laparoscopic pancreatoduodenectomy,LPD)以来,有关学者一直在开展腹腔镜或机器人辅助技术应用于胰腺外科的探索工作</span><sup style="color: #666666;">[1]</sup><span style="color: #666666;">。近十年来,临床上陆续开展以腹腔镜或机器人辅助为主的各类胰腺微创手术,技术趋于成熟,手术安全性明显提高。理论上,腹腔镜或机器人辅助手术能开展的胰腺手术类型与开放手术已几乎无差异,</span></p>, tagList=[TagDto(tagId=696, tagName=腹腔镜), TagDto(tagId=5553, tagName=机器人辅助), TagDto(tagId=472484, tagName=胰腺癌根治术)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1476, appHits=45, showAppHits=0, pcHits=183, showPcHits=1431, likes=0, shares=5, comments=3, approvalStatus=1, publishedTime=Fri Mar 03 17:45:37 CST 2023, publishedTimeString=2023-02-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Mar 03 17:44:06 CST 2023, updatedBy=4754896, updatedName=侠胆医心, updatedTime=Wed Jan 03 14:23:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=四川省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版).pdf)])
腹腔镜或机器人辅助胰腺癌根治术中国专家共识(2022版).pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2133807, encodeId=6022213380ec9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sun May 14 22:25:41 CST 2023, time=2023-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2130501, encodeId=108e2130501ed, content=高精尖, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43cc5507950, createdName=ms8000001335780189, createdTime=Sat May 06 17:27:13 CST 2023, time=2023-05-06, status=1, ipAttribution=新疆)]
    2023-05-14 ms3000000173679460 来自四川省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2133807, encodeId=6022213380ec9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8d88266800, createdName=ms3000000173679460, createdTime=Sun May 14 22:25:41 CST 2023, time=2023-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2130501, encodeId=108e2130501ed, content=高精尖, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43cc5507950, createdName=ms8000001335780189, createdTime=Sat May 06 17:27:13 CST 2023, time=2023-05-06, status=1, ipAttribution=新疆)]
    2023-05-06 ms8000001335780189 来自新疆

    高精尖

    0